Episoder
-
Jane spoke to Paul Tait, lead Palliative Care Pharmacist for the Southern Adelaide Local Health Network
We spoke about:The differing presentations of palliative care patients.
Interventions to improve access to end of life medicines for community palliative care patients.
Useful resources for health professionals.
-
Jane and Dan spoke to Kate O'Hara, Lead Pharmacist for Women, Youth and Children at The Canberra Hospital.
We talk about:
The many ways that paediatric patients are different to adults Pharmacokinetic differences between adults and children Off-label use of medicines in paediatrics and the associated practicalities -
Manglende episoder?
-
At the recent 2017 SHPA Residency Symposium, Dan joined Beth Ward, Foundation Program Manager at the Royal Pharmaceutical Society and Ian Coombes, SHPA Vice President and Director of Pharmacy at the Royal Brisbane and Women's Hospital to discuss plans and programs to support and develop our workforce.
-
Jane sat down with Dr Chris Leung from Austin Health. Chris is a gastroenterologist, medical lead for clinical education and local clinical lead for Choosing Wisely.
Jane and Chris talk about: the reasons why proton pump inhibitors (PPIs) are in the top 10 most commonly prescribed medicines in Australia the problems associated with long-term PPIs The general principles of the Choosing Wisely campaign in Australia -
Dan sat down with Nashwa Masnoon, a PhD student at the University of South Australia and pharmacist at the Royal Adelaide Hospital, and Professor Sepehr Shakib Director of Clinical Pharmacology at the Royal Adelaide Hospital.
Nashwa and Sepehr spoke to Dan about a new web-based tool that they have developed: WIPE (What is Polypharmacy Exactly?).
The WIPE tool is being used to gauge opinions of Australian clinicians about what polypharmacy means in practice. Users are presented with cases and asked to rate the risk of medicine-related harm. The results will be used to inform a working definition for polypharmacy in Australia.
You can access the WIPE tool here: wipe.logicsquad.net/signup
-
Jane and Dan spoke to Dr Rohan Elliott, senior pharmacist in aged care at Austin Health, adjunct senior lecturer at Monash University, and a research consultant with the Royal District Nursing Service Institute.
We talk to Rohan about:
· The definition of geriatric medicine, and what it means to be frail
· How the geriatric medicine approach differs from other specialties
· Decision making in geriatric medicine
-
Jane and Dan talk to Hao Vo-Tran, a pharmacist at the Royal Women’s Hospital in Melbourne and editor of the Royal Women’s Hospital Pregnancy and Breastfeeding Medicines Guide.
We talk to Hao about: General principles in evaluating the safety of medicines in pregnancy and breastfeeding. Limitations of the TGA categorisation system for prescribing medicines in pregnancy Strategies for discussing risks with patients -
Jane and Dan chat to Dr Jacinta Johnson, Specialist Pharmacist, Clinical Educator and Lecturer in Pharmacy at the University of South Australia.
We talk to Jacinta about
The risks from codeine and the reasons behind the decision to reschedule it to a prescription-only medicine. Whether or not there is a role for codeine as an analgesic. Alternative non-prescription analgesic options -
Jane sat down with Gillian Swinnerton and Jerry Yik from the Pharmacists’ Support Service.
We talk about the Pharmacists' Support Service (PSS) and the help that they provide.
To contact the Pharmacists' Support Service call 1300 244 910
-
Jane and Dan chat to Dr Jo Grace, a gastroenterologist and hepatologist from Austin Health.
We talk to Jo about:
What we have learned from 12 months of subsidised Hep C treatment in Australia Clinical considerations when treating patients with direct acting antiviral agents Future directions in hepatitis C: long term outcomes and new pangenotypical treatments -
Jim Siderov is the senior Oncology Pharmacist at Austin Health. He is also an Australian Advanced Practice Pharmacist and is US Board Certified in Oncology Pharmacy.
We speak to Jim about:
Checkpoint inhibitors: their mechanism and role in oncology Autoimmune toxicities and how they are managed clinically Emerging evidence and future potential uses for these agents -
Dan and Jane are joined by Kristin Michaels, SHPA CEO and Professor Michael Dooley, SHPA President to discuss the proposed changes to the constitution and respond to members frequently asked questions.
-
Jane visited TAPNA 2017, the scientific meeting of the Toxicology and Poisons Network of Australasia. She spoke to Dr Kent Olson, keynote speaker and Medical Director of the San Francisco Division of the California Poison Control System. Also joining the discussion are two TAPNA attendees: Andrew Harding, Senior Emergency Department Pharmacist at Austin Health and Brett Anderson, Pharmacy Resident at Austin Health.
We talk about:
controversies in toxicology and their relevance to pharmacists: charcoal, digoxin-specific antibody and antivenoms emerging trends in illicit and prescription medicine abuse new models for accessing information about poisons and medicines -
In the 20th episode of the podcast Jane and Dan continue their chat with Dr Rochelle Gellatly. Rochelle is a clinical pharmacy specialist in critical care, an Australian Advanced Practice Pharmacist in Cardiology and a Board Certified Pharmacotherapy Specialist with added qualifications in Cardiology.
We talk to Rochelle about:
the viscious cycle of heart failure (you might need to take notes) the different types of heart failure: HFrEF and HFpEF the newer agents for heart failure: sacubitril and ivabradine -
Heather Cleland, Director of the Victorian Adult Burns Unit at The Alfred join Jane and Dan to discuss the work of the Unit, the management of major burns and medication usage in this special population
-
Jane and Dan are joined by Lisa Pont, SHPA Federal Councillor and chair of the National Translational Research Collaborative to discuss how to get your research started, done and published. Lisa also talks about how she is eagerly awaiting her copy of SHPA's new journal "Pharmacy Growth, Research, Innovation and Training - GRIT"
-
Jane and Dan speak to Emma Dean, smoking cessation co-ordinator at Alfred Health.
We talk to Emma about:
The optimal time to start a conversation about smoking cessation The ideal regimen and dosing for nicotine replacement therapy Whether e-cigarettes are a helpful alternative to conventional cigarettes The current thinking about varenicline and neuropsychiatric adverse effects -
Jane and Dan talk to Professor Tina Brock, Human of Pharmacy and Professor of Pharmacy Education and Practice at Monash University. We talk to Tina about:
Her journey from Mississippi to Melbourne What inter-professional learning means in practice What goes wrong in inter-professional collaboration and how we can be better at it Opportunities in automation and disruption What your online avatar says about you -
Jane and Dan chat to Dr Rochelle Gellatly, a clinical pharmacy specialist in critical care, an Australian Advanced Practice Pharmacist in Cardiology and a Board Certified Pharmacotherapy Specialist with added qualifications in Cardiology. She is currently working in Vancouver.
We talk to Rochelle about:
Recent changes in thinking about hyperlipidaemia, target LDLs and risk assessment How scores for cardiovascular risk are used in practice What we know (or don’t) about the optimal dose of a statin and the frequency of adverse events -
Jane and Dan speak to Professor Geoff Isbister is a clinical toxicologist and
Director of Clinical Toxicology at the University of Newcastle.
We talk to Geoff about:
The spectrum of clinical presentations of serotonin toxicity
Significant drug interactions with SSRIs: tramadol or linezolid?
Current trends in pharmaceutical overdose
Whether antivenoms are useful (and a shout out to our overseas listeners) - Vis mere
